{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:01:56Z","timestamp":1788289316262,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Malaria has always been a serious infectious disease prevalent in the world. Antimalarial drugs such as chloroquine and artemisinin have been the main compounds used to treat malaria. However, the massive use of this type of drugs accelerates the evolution and spread of malaria parasites, leading to the development of resistance. A large number of related data have been published by researchers in recent years. CiteSpace software has gained popularity among us researchers in recent years, because of its ability to help us obtain the core information we want in a mass of articles. In order to analyze the hotspots and develop trends in this field through visual analysis, this study used CiteSpace software to summarize the available data in the literature to provide insights.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Relevant literature was collected from the Web of Science Core Collection (WOSCC) from 1 January 2015 to 29 March 2023. CiteSpace software and Microsoft Excel were used to analyze and present the data, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2,561 literatures were retrieved and 2,559 literatures were included in the analysis after the removal of duplicates. An irrefutable witness of the ever-growing interest in the topic of antimalarial drug resistance could be expressed by the exponentially increased number of publications and related citations from 2015 to 2022, and its sustained growth trend by 2023. During the past 7 years, USA, Oxford University, and David A Fidock are the country, institution, and author with the most publications in this field of research, respectively. We focused on the references and keywords from literature and found that the research and development of new drugs is the newest hotspot in this field. A growing number of scientists are devoted to finding new antimalarial drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study is the first visual metrological analysis of antimalarial drug resistance, using bibliometric methods. As a baseline information, it is important to analyze research output published globally on antimalarial drug resistance. In order to better understand the current research situation and future research plan agenda, such baseline data are needed accordingly.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1270060","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T04:44:26Z","timestamp":1707713066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Bibliometric analysis of antimalarial drug resistance"],"prefix":"10.3389","volume":"14","author":[{"given":"Jialu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.parint.2019.03.001","article-title":"Polymorphisms in genes associated with drug resistance of Plasmodium vivax in India","volume":"70","author":"Anantabotla","year":"2019","journal-title":"Parasitol. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baraga\u00f1a","year":"2015","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpddr.2022.11.001","article-title":"Current and emerging target identification methods for novel antimalarials","volume":"20","author":"Challis","year":"2022","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.626502","article-title":"Bibliometric analysis of the inflammasome and pyroptosis in brain","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","article-title":"Evolution of partial resistance to artemisinins in malaria parasites in Uganda","volume":"389","author":"Conrad","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"Dondorp","year":"2010","journal-title":"Lancet Lond. Engl."},{"key":"B12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B13","unstructured":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","article-title":"Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia","volume":"8","author":"Fola","year":"2023","journal-title":"Nat. Microbiol."},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2023.06.001","volume-title":"Profiling the Antimalarial Mechanism of Artemisinin by Identifying Crucial Target Proteins","author":"Gao","year":"2023"},{"key":"B16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1021\/acsinfecdis.7b00159","article-title":"Biological studies and target engagement of the 2- C-methyl-d-erythritol 4-phosphate cytidylyltransferase (IspD)-targeting antimalarial agent (1 R,3 S)-MMV008138 and analogs","volume":"4","author":"Ghavami","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.pt.2019.05.002","article-title":"Ozonide antimalarial activity in the context of artemisinin-resistant malaria","volume":"35","author":"Giannangelo","year":"2019","journal-title":"Trends Parasitol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235401","article-title":"Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017","volume":"15","author":"Hussien","year":"2020","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acsinfecdis.2c00527","article-title":"Fast-killing tyrosine amide ((S)-SW228703) with blood- and liver-stage antimalarial activity associated with the cyclic amine resistance locus (PfCARL)","volume":"9","author":"Imlay","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1016\/S2214-109X(22)00285-6","article-title":"The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysis","volume":"10","author":"Kiarie","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(18)30792-X","article-title":"Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme","volume":"391","author":"Landier","year":"2018","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1473-3099(17)30171-8","article-title":"Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a\/1b randomised study","volume":"17","author":"McCarthy","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12916-018-1172-x","article-title":"Malaria elimination in remote communities requires integration of malaria control activities into general health care: an observational study and interrupted time series analysis in Myanmar","volume":"16","author":"McLean","year":"2018","journal-title":"BMC Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1473-3099(18)30071-9","article-title":"Multidrug-resistant Plasmodium falciparum malaria in the Greater Mekong subregion","volume":"18","author":"M\u00e9nard","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"M\u00e9nard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/infdis\/jiaa286","article-title":"Evolution of antimalarial drug resistance markers in the reservoir of plasmodium falciparum infections in the upper east region of Ghana","volume":"222","author":"Narh","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac083","article-title":"Trends in imported malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network)","volume":"29","author":"Norman","year":"2022","journal-title":"J. Travel Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12936-021-03987-6","article-title":"Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum","volume":"20","author":"Owoloye","year":"2021","journal-title":"Malar. J."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","article-title":"Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial","volume":"16","author":"Phyo","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/srep14552","article-title":"Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite\u2019s food vacuole and alter drug sensitivities","volume":"5","author":"Pulcini","year":"2015","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gene.2018.06.084","article-title":"Deciphering the role of IspD (2\u2212C\u2212methyl\u2212D\u2212erythritol 4\u2212phosphate cytidyltransferase) enzyme as a potential therapeutic drug target against Plasmodium vivax","volume":"675","author":"Saggu","year":"2018","journal-title":"Gene"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1161\u20131163","DOI":"10.1093\/cid\/ciad061","article-title":"Return to travel in the coronavirus disease 2019 pandemic recovery period and implications for imported malaria: reinforcing prevention, early diagnosis, and appropriate treatment of malaria","volume":"76","author":"Schultz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.2147\/IDR.S279433","article-title":"Antimalarial drug resistance and novel targets for antimalarial drug discovery","volume":"13","author":"Shibeshi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"B40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1021\/acsinfecdis.1c00550","article-title":"Peroxide antimalarial drugs target redox homeostasis in plasmodium falciparum infected red blood cells","volume":"8","author":"Siddiqui","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e00172","DOI":"10.1128\/mBio.00172-17","article-title":"Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro","volume":"8","author":"Straimer","year":"2017","journal-title":"mBio"},{"key":"B42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","article-title":"Molecular mechanisms of drug resistance in plasmodium falciparum malaria","volume":"74","author":"Wicht","year":"2020","journal-title":"Annu. Rev. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/femsre\/fuw037","article-title":"The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread","volume":"41","author":"Woodrow","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B49","article-title":"World malaria report","year":"2013"},{"key":"B50","article-title":"Guidelines for the treatment of malaria, 3rd ed","year":"2015"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","article-title":"Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"14962","DOI":"10.1074\/jbc.RA118.004558","article-title":"Structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase\u2013dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance","volume":"293","author":"Yogavel","year":"2018","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1270060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T04:44:31Z","timestamp":1707713071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1270060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":52,"alternative-id":["10.3389\/fcimb.2024.1270060"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1270060","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"article-number":"1270060"}}